These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Lindon JC; Holmes E; Bollard ME; Stanley EG; Nicholson JK Biomarkers; 2004; 9(1):1-31. PubMed ID: 15204308 [TBL] [Abstract][Full Text] [Related]
7. [Recent advances in metabonomics]. Xu GW; Lu X; Yang SL Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):701-11. PubMed ID: 18595244 [TBL] [Abstract][Full Text] [Related]
8. Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy. Nicholson JK; Everett JR; Lindon JC Expert Opin Drug Metab Toxicol; 2012 Feb; 8(2):135-9. PubMed ID: 22248264 [TBL] [Abstract][Full Text] [Related]
10. Metabonomics for discovering biomarkers of hepatotoxicity and nephrotoxicity. Zhang A; Sun H; Wang P; Han Y; Wang X Pharmazie; 2012 Feb; 67(2):99-105. PubMed ID: 22512077 [TBL] [Abstract][Full Text] [Related]
11. [Role of biomarkers in toxicity treatment "metabonomics" as a new biomarker discovery method]. Naraoka H; Suzumura K; Takeuchi K; Sasayama T Rinsho Byori; 2008 Apr; 56(4):335-42. PubMed ID: 18516969 [TBL] [Abstract][Full Text] [Related]
12. Metabonomics: its potential as a tool in toxicology for safety assessment and data integration. Griffin JL; Bollard ME Curr Drug Metab; 2004 Oct; 5(5):389-98. PubMed ID: 15544433 [TBL] [Abstract][Full Text] [Related]
13. Metabolites in safety testing: metabolite identification strategies in discovery and development. Nedderman AN Biopharm Drug Dispos; 2009 May; 30(4):153-62. PubMed ID: 19544286 [TBL] [Abstract][Full Text] [Related]
14. Metabonomics techniques and applications to pharmaceutical research & development. Lindon JC; Holmes E; Nicholson JK Pharm Res; 2006 Jun; 23(6):1075-88. PubMed ID: 16715371 [TBL] [Abstract][Full Text] [Related]
15. Metabolomics and biochemical profiling in drug discovery and development. Watkins SM; German JB Curr Opin Mol Ther; 2002 Jun; 4(3):224-8. PubMed ID: 12139307 [TBL] [Abstract][Full Text] [Related]
16. Biomarker discovery for drug development and translational medicine using metabonomics. Keun HC Ernst Schering Found Symp Proc; 2007; (4):79-98. PubMed ID: 18811054 [TBL] [Abstract][Full Text] [Related]
17. Metabonomics in toxicology: a review. Robertson DG Toxicol Sci; 2005 Jun; 85(2):809-22. PubMed ID: 15689416 [TBL] [Abstract][Full Text] [Related]
18. The role of metabonomics at the interface between drug metabolism and safety assessment. Waters NJ Curr Drug Metab; 2010 Oct; 11(8):686-92. PubMed ID: 20973758 [TBL] [Abstract][Full Text] [Related]
19. Metabonomics: a useful tool for the future surgeon. Goldsmith P; Fenton H; Morris-Stiff G; Ahmad N; Fisher J; Prasad KR J Surg Res; 2010 May; 160(1):122-32. PubMed ID: 19592031 [TBL] [Abstract][Full Text] [Related]